Skip to content

Effect of losartan with whole bain radiotherapy in brain metastasis

Radiologic response evaloution after conventional whole brain radiation therapy plus concurrent oral adminestration of losartan versus radiotion therapy alone in patients with brain metastasis

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170314033080N2
Enrollment
60
Registered
2018-03-11
Start date
2018-03-21
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain metastasis. Malignant neoplasm of brain

Interventions

Intervention 1: Intervention group: whole brain radiation with 30 Gray in 10 fractions and using 25 mg losartan tablet during radition course. Intervention 2: Control group: standard treatment with wh

Sponsors

Ahvaz Jundi Shapour university of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Extracranial metastasis confirmed by pathology MRI imaging suggestive for brain metastasias with at least 1 cm in size Predicted survival at least 8 weeks for patient Zubrud performance scale 0, 1, 2, 3 Absolout neutrophil count>1000 in mm3 Serum platlet >50000 in mm3 Serum Cratinin< 1.5 mg/d BUN<25 in dl Serum potassium 3.5-5 mmol/L Get informed consent

Exclusion criteria

Exclusion criteria: ?Sever mental or physical illness disturbing treatment according protocole Previous brain radiotherapy or radiosurgery Patients wihtout regular follow-up Age90 years Previous treatment with ACEI/ARB drugs Pregnancy Baseline hypotenssion Leptomeningeal involvment

Design outcomes

Primary

MeasureTime frame
Radiologic response of brain metastatic lesion. Timepoint: 6 weeks after ending of intervention. Method of measurement: RECIST V1.1criteria for response evaluation in solid tumors.

Secondary

MeasureTime frame
Radiologic response of non target metastatic brain lesion. Timepoint: 6 weeks after ending intervention. Method of measurement: RECIST v 1.1 criteria for response evaluation in solid tumors.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYasamin Mahouram

Ahvaz Jundishapour University Of Medical Science

mahouram.y@ajums.ac.ir+98 61 3321 9277

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026